WA People
BILL · 2023–24 SESSION · LATEST VERSION 2SHB 1745

HB 1745: Diversity in clinical trials

Improving diversity in clinical trials.

Summary

  • Requires the Washington State Institutional Review Board (Review Board) to establish a diversity in clinical trials program.
  • Requires the Department of Health (DOH), in consultation with others, to analyze and provide recommendations on matters related to increasing participation by underrepresented groups in clinical trials and provide a report to the Legislature.
  • Authorizes the Andy Hill Cancer Research Endowment (Andy Hill Endowment), subject to appropriation, to provide grant funding to community-based organizations to provide outreach and engagement for specific clinical trials at the request of the University of Washington or Washington State University based on a community outreach and engagement plan developed by the requesting university, the Andy Hill Endowment, the DOH, and community-based organizations.
  • Requires any state entity or hospital that receives National Institutes of Health funding for drug and medical device clinical trials to adopt a policy concerning identification and recruitment of persons who are members of underrepresented demographic groups to participate in clinical trials, offer information in languages other than English, provide translation services or bilingual staff, provide culturally specific recruitment materials, and provide electronic consent when available.

From the Second Substitute House Bill Report (2SHB 1745), written by the Legislature's nonpartisan staff. Read the full report ↗

Enacted Enacted · Chapter 426, Laws of 2023
  1. IntroducedFeb 3, 2023
  2. Out of committeeFeb 24, 2023
  3. Passed HouseMar 6, 2023
  4. Passed SenateApr 12, 2023
  5. GovernorMay 11, 2023
  6. LawMay 11, 2023
Prime sponsor
My-Linh Thai (D-41)
Introduced
February 3, 2023 in the House
Last action
May 11, 2023
Session law
Chapter 426, Laws of 2023
Budget
Has a fiscal note
Versions
HB 1745, SHB 1745, 2SHB 1745

AN ACT Relating to improving diversity in clinical trials;

Sponsors

Prime sponsor: My-Linh Thai (D-41)

4 co-sponsors (4 Democrats, 0 Republicans)

Davina Duerr D-1Beth Doglio D-22Timm Ormsby D-3Nicole Macri D-43

Votes

House · 3rd Reading & Final Passage

Passed March 6, 2023
Version voted on: 2SHB 1745
95 Yea 0 Nay 0 Absent 3 Excused
PartyYeaNayAbsentExcused
Democrat57001
Republican38002
How each member voted

Yea (95)

Excused (3)

Permalink to this vote

Senate · 3rd Reading & Final Passage as Amended by the Senate

Passed April 12, 2023
Version voted on: 2SHB 1745
49 Yea 0 Nay 0 Absent 0 Excused
PartyYeaNayAbsentExcused
Democrat29000
Republican20000
How each member voted

Yea (49)

Permalink to this vote

House · Final Passage as Amended by the Senate

Passed April 19, 2023
Version voted on: 2SHB 1745
98 Yea 0 Nay 0 Absent 0 Excused
PartyYeaNayAbsentExcused
Democrat58000
Republican40000
How each member voted

Yea (98)

Permalink to this vote

History

  1. Effective date 7/23/2023. (2SHB 1745)
  2. Chapter 426, 2023 Laws. (2SHB 1745)
  3. Governor signed. (2SHB 1745)
  4. Delivered to Governor. (2SHB 1745)
  5. Speaker signed. (2SHB 1745)
  6. President signed. (2SHB 1745)
  7. Passed final passage; yeas, 98; nays, 0; absent, 0; excused, 0. (2SHB 1745)
  8. House concurred in Senate amendments. (2SHB 1745)
  9. Third reading, passed; yeas, 49; nays, 0; absent, 0; excused, 0. (2SHB 1745)
  10. Rules suspended. Placed on Third Reading. (2SHB 1745)
  11. Floor amendment(s) adopted. (2SHB 1745)
  12. Committee amendment not adopted. (2SHB 1745)
  13. Placed on second reading by Rules Committee. (2SHB 1745)
  14. Passed to Rules Committee for second reading. (2SHB 1745)
  15. Minority; without recommendation. (2SHB 1745)
  16. WM - Majority; do pass with amendment(s). (2SHB 1745)
  17. Referred to Ways & Means. (2SHB 1745)
  18. And refer to Ways & Means. (2SHB 1745)
  19. HLTC - Majority; do pass with amendment(s). (2SHB 1745)
  20. First reading, referred to Health & Long Term Care. (2SHB 1745)
  21. Third reading, passed; yeas, 95; nays, 0; absent, 0; excused, 3. (2SHB 1745)
  22. Rules suspended. Placed on Third Reading. (2SHB 1745)
  23. 2nd substitute bill substituted. (2SHB 1745)
  24. 2nd substitute bill substituted. (SHB 1745)
  25. 2nd substitute bill substituted.
  26. Rules Committee relieved of further consideration. Placed on second reading. (2SHB 1745)
  27. Rules Committee relieved of further consideration. Placed on second reading. (SHB 1745)
  28. Rules Committee relieved of further consideration. Placed on second reading.
  29. Referred to Rules 2 Review. (2SHB 1745)
  30. APP - Majority; 2nd substitute bill be substituted, do pass. (2SHB 1745)
  31. APP - Executive action taken by committee. (SHB 1745)
  32. APP - Majority; 2nd substitute bill be substituted, do pass. (SHB 1745)
  33. Referred to Rules 2 Review. (SHB 1745)
  34. Referred to Rules 2 Review.
  35. APP - Majority; 2nd substitute bill be substituted, do pass.
  36. APP - Executive action taken by committee.
  37. Referred to Appropriations. (SHB 1745)
  38. HCW - Majority; 1st substitute bill be substituted, do pass. (SHB 1745)
  39. HCW - Majority; 1st substitute bill be substituted, do pass.
  40. Referred to Appropriations.
  41. HCW - Executive action taken by committee.
  42. First reading, referred to Health Care & Wellness.

HB 1745 in other sessions

Bill numbers restart every two years, so the same number is a different bill in each session.

Report wrong or missing information on this page